基础医学与临床 ›› 2019, Vol. 39 ›› Issue (7): 1057-1060.

• 短篇综述 • 上一篇    下一篇

铁死亡在肿瘤中的研究进展

陈云霞1,史志周2   

  1. 1. 昆明理工大学
    2. 云南省昆明市昆明理工大学
  • 收稿日期:2018-11-28 修回日期:2019-04-21 出版日期:2019-07-05 发布日期:2019-07-02
  • 通讯作者: 陈云霞 E-mail:1649893370@qq.com
  • 基金资助:
    miR-145-5p靶向调控c-myc促进食管癌细胞铁死亡的分子机制研究

Research progress of ferroptosis in tumor

,   

  • Received:2018-11-28 Revised:2019-04-21 Online:2019-07-05 Published:2019-07-02

摘要: 铁死亡是近几年发现的不同于坏死和凋亡的一种新的程序性细胞死亡方式,其特征是铁依赖的脂质过氧化物积累到致死水平。铁死亡参与肝癌、胰腺癌、前列腺癌和乳腺癌等多种肿瘤的发生发展过程。SLC7A11和GPX4是铁死亡关键的调控基因,p53和BECN1等分子通过调控SLC7A11和GPX4参与铁死亡的调控,同时诱导肿瘤细胞铁死亡有望成为抗肿瘤治疗的新策略。

关键词: 肿瘤, 铁死亡, 铁死亡诱导剂, 抗肿瘤

Abstract: Ferroptosis, which is different from necrosis and apoptosis is a newly discovered programmed cell death. The characteristic of ferroptosis is the iron-dependent accumulation of lipid hydroperoxides to lethal levels. Ferroptosis is involved in the formation and development of different cancers such as hepatocellular cancer, pancreatic cancer, prostate cancer and breast cancer. SLC7A11 and GPX4 are the key regulators in ferroptosis; p53 and BECN1 participate in the ferroptosis via regulating SLC7A11 and GPX4; Inducing ferroptosis might become a new antitumor method in future.

Key words: tumor, ferroptosis, ferroptosis inducer, anticancer

中图分类号: